RenovoRx (RNXT) Free Cash Flow (2020 - 2026)
RenovoRx (RNXT) posted Free Cash Flow of -$3.7 million for Q1 2026, down 22.81% sequentially from -$3.0 million in Q4 2025, and down 9.7% YoY from -$4.1 million in Q1 2025.
RenovoRx (RNXT) Free Cash Flow (2020 - 2026) Analysis & Trends
RenovoRx has reported Free Cash Flow for 7 years, with the latest figure at -$3.7 million in Q1 2026.
- Quarterly Free Cash Flow fell 9.7% year-over-year to -$3.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$11.3 million (down 9.72% YoY) and the FY2025 annual result came in at -$11.0 million, down 20.12% from the prior year.
- Free Cash Flow eased to -$3.7 million in Q1 2026 per RNXT's latest filing, from -$3.0 million in the prior quarter.
- Over five years, Free Cash Flow peaked at -$1.7 million in Q4 2022 and troughed at -$3.7 million in Q1 2026.
- A 5-year average of -$2.5 million and a median of -$2.4 million in 2022 frame the typical range for Free Cash Flow.
- The widest YoY moves for Free Cash Flow: up 34.28% in 2022, down 138.78% in 2022.
- Over 5 years, Free Cash Flow stood at -$1.7 million in 2022, then retreated by 22.13% to -$2.1 million in 2023, then dropped by 18.36% to -$2.4 million in 2024, then dropped by 24.28% to -$3.0 million in 2025, then dropped by 22.81% to -$3.7 million in 2026.
- According to Business Quant data, Free Cash Flow over the past three periods registered -$3.7 million, -$3.0 million, and -$2.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.01 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 572.80 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -563.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 437.80 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 292.04 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -95.09 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 477.44 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 433.84 Mn |
| 10 | RenovoRx | 61.96 Mn | 61.96 Mn | 766,000.00 | -3.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.00 Mn |
| Jun 30, 2026 | -3.00 Mn |
| Mar 31, 2026 | -3.71 Mn |
| Mar 31, 2026 | -3.71 Mn |
| Dec 31, 2025 | -3.02 Mn |
| Dec 31, 2025 | -3.02 Mn |
| Sep 30, 2025 | -2.27 Mn |
| Sep 30, 2025 | -2.27 Mn |
| Jun 30, 2025 | -2.30 Mn |
| Jun 30, 2025 | -2.30 Mn |
| Mar 31, 2025 | -3.38 Mn |
| Mar 31, 2025 | -3.38 Mn |
| Dec 31, 2024 | -2.43 Mn |
| Dec 31, 2024 | -2.43 Mn |
| Sep 30, 2024 | -2.19 Mn |
| Sep 30, 2024 | -2.19 Mn |
| Jun 30, 2024 | -2.30 Mn |
| Jun 30, 2024 | -2.30 Mn |
| Mar 31, 2024 | -2.20 Mn |
| Mar 31, 2024 | -2.20 Mn |